Search clinical trials for: Adverse Events

Total 4314 results

AbbVie

Withdrawn

A Study To Assess Adverse Events and Change in Disease Activity With Oral Cariprazine When Added to Antidepressant Therapies (ADTs) Compared to Placebo in Adult Participants With Generalized Anxiety Disorder (GAD) Who Have Had an Inadequate Response to ADTs Alone (CAR aGAD Ph 2)

Generalized Anxiety Disorder

United States
Qian geng

Completed

Predictive Value of Cardiovascular Magnetic Resonance Related Parameters in STEMI Patients After Primary PCI for Adverse Left Ventricular Remodeling and Major Adverse Cardiovascular Events

Cardiovascular Diseases

China
Nasim Tabrizi
Mazandaran University of Medical Sciences

Completed

Effect of Pyridoxine on Behavioral Adverse Events of Levetiracetam (EPYLEB)

Epilepsy | Behavior Problem | Pyridoxine

Iran, Islamic Republic of
Anna Vlasova
Russian Medical Academy of Continuous Professional Education; Morozov Children...

Completed

Safety Analysis of Antimicrobial Pharmacotherapy in Intensive Care Unit at Pediatric Hospital

Drug Therapy

Russian Federation
Azienda USL Modena

Completed

1L-PEG-Asc Solution for Bowel Preparation in an "Open Access" Colonoscopy Booking System: Evaluation of Adverse Events

Bowel Preparation

Italy
Organon and Co

Completed

Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1)

Arthritis | Osteoarthritis | Rheumatoid Arthritis | Gout | Ankylosing Spondylitis
Brigham and Women's Hospital
Crico

Completed

PREventing Adverse Events Post-Discharge Through Proactive Identification, Multidisciplinary Communication, and Technology (PREDICT)

Adverse Event | Transitions of Care | General Medicine | Discharge Checklist

United States
T.C. ORDU ÜNİVERSİTESİ

Completed

The Effect of Intracameral Carbachol and Epinephrine on Choroidal Thickness

Cataract | Choroid Disease | Epinephrine Toxicity | Carbachol Adverse Reaction

Turkey
Viriom

Completed

Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral Drugs

Hepatic Impairment | HIV-1-infection

Russian Federation
Great Ormond Street Hospital for Children NHS Foundation...
University College, London

Completed

Identifying and Understanding Risk Factors for Instability and Adverse Events Associated With Chest Physiotherapy in Ventilated Children (REACH)

Respiratory Failure

United Kingdom
Novartis Pharmaceuticals

Completed

Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Agerelated Macular Degeneration (AMD) Who Received Anti-VEGF Agents (IRIS Registry)

Age-related Macular Degeneration (AMD)

United States
Tampere University Hospital

Active, not recruiting

Electronically Recorded National Early Warning Scores, Pain Scores and PONV Scores Among Hospitalized Patients

Prevention of In-hospital Adverse Events

Finland
Novartis Pharmaceuticals

Completed

Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Age-related Macular Degeneration (AMD) Who Received Anti-vascular Endothelial Growth Factor (VEGF) Agents (Komodo Health)

Age-related Macular Degeneration (AMD)

United States
University Hospital, Bordeaux

Completed

REnal TRansplant Outcomes After CARdiac Surgery (RETROCAR) (RETROCAR)

Cardiac Surgery | Cardiopulmonary Bypass | Renal Transplant Recipient

France
University of Monastir

Completed

Prognostic Value of Non-invasive Index of Endothelial Function.

Chest Pain | Major Adverse Cardiovascular Events

Tunisia
Penumbra Inc.

Completed

Imaging Guided Patient Selection for Interventional Revascularization Therapy (START)

Acute Ischemic Stroke

United States
Pfizer

Withdrawn

A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery

Pulmonary Embolism | Cerebral Stroke | Thrombosis, Deep Vein
University of British Columbia
Providence Health & Services; Vancouver Coastal Health

Withdrawn

Colchicine Prevents Myocardial Injury After Non-Cardiac Surgery Pilot Study (COPMAN)

Myocardial Infarction | Myocardial Injury | Major Adverse Cardiac Events | Infectious Complications

Canada
University of Thessaly

Completed

MACE and PE in Elective Primary TKA & THA

Stroke | Death | Transient Ischemic Attack | Pulmonary Embolism | Cardiovascular Complication

Greece
Pfizer

Withdrawn

A Study of Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) Treatment

Pulmonary Embolism | Thrombosis, Deep Vein
University Hospital, Montpellier

Completed

Drug-Related Problems : Focus on Age and Diabetes (DRP-AD)

Adverse Drug Events

France
University of Copenhagen
Zealand University Hospital

Completed

The Relationship Between Fat Free Mass and Toxicity of Cytostatics in Cancer Patients

Colorectal Cancer | Pancreas Cancer

Denmark
Guangdong Provincial People's Hospital
First Affiliated Hospital of Fujian Medical University; Shenzhen People's Hospital and other collaborators

Completed

Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention II

Coronary Artery Disease | Kidney Diseases | Metabolic Syndrome | Cardio-Renal Syndrome | Coronary Angiography

China
Rong Tao

Completed

Social Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL Patients

Extranodal NK-T-Cell Lymphoma, Nasal Type

China
Guangdong Provincial People's Hospital

Completed

Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention

Coronary Artery Disease | Kidney Diseases | Metabolic Syndrome | Cardio-Renal Syndrome | Coronary Angiography

China
AbbVie

Completed

Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)

CoronaVirus Disease-2019 (COVID-19)

United States, Hungary, Israel, Netherlands, Puerto Rico
Bozyaka Training and Research Hospital

Completed

Adverse Events Report of Inactivated COVID-19 Vaccine

COVID-19 | Vaccine Adverse Reaction

Turkey
Manuel Sanchez Luna

Completed

Risk Related Assistance During Stabilization In Newborns At Birth

Infant, Newborn

Spain
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Completed

Aprepitant Effects in Intravenous Heroin Dependence

Opioid Dependence

United States
Resverlogix Corp
PPD; ICON plc; Medidata Solutions

Completed

Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD (BETonMACE)

Coronary Artery Disease | Diabetes Mellitus, Type 2

Netherlands, Taiwan, Argentina, Israel, Poland, Russian Federation, Australia, Belgium, Serbia, Bulgaria, Hungary, Slovakia, Mexico, Croatia, Germany
Associacao de Investigacao de Cuidados de Suporte...
Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.; University Institute...

Terminated

Acute and Long-term Impact of Cancer Treatment on Head and Neck Cancer Patients: FIT4TREATMENT (F4T)

Head and Neck Neoplasms

Portugal
KU Leuven

Completed

Emergency Department Crowding in Relation to In-hospital Adverse Medical Events

Adverse Effects

Belgium
Massachusetts General Hospital

Completed

Usability of a Perioperative Medication-Related Clinical Decision Support Application

Perioperative Medication Errors | Perioperative Adverse Medication Events

United States
Quark Pharmaceuticals

Terminated

QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery

Cardiac Surgery

United States, Germany, Spain, Australia, Austria, Canada, New Zealand, United Kingdom, Belgium, Czechia, France
Bayer

Completed

Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors.

Oncology

United States
Novartis Pharmaceuticals

Completed

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment (MACS0999)

Chronic Myelogenous Leukemia

United States, Canada
Unity Health Toronto

Terminated

Hemoglobin Optimization to Prevent Transfusion and Adverse Events in Perioperative Patients With Iron Restricted Anemia (HOPE-Hb)

Anemia, Iron Deficiency | Knee Arthropathy | Hip Arthropathy | Anemia of Chronic Disease

Canada
AB Biotics, SA
Hospital Clinic of Barcelona

Completed

Utility of the Pharmacogenetic Information Provided by NEUROPHARMAGEN in the Treatment of Bipolar Depressionwith Bipolar Depression

Bipolar Disorder

Spain
Laboratorios Silanes S.A. de C.V.

Completed

Safety of doTBal® in Patients With Tuberculosis: Conduction of an Intensive Pharmacovigilance Program

Tuberculosis

Mexico
Orion Corporation, Orion Pharma

Completed

Dose-finding Pharmacokinetic Study in Healthy Males (COMDOS1)

Healthy Volunteers

Germany
McGill University Health Centre/Research Institute...
University Health Network, Toronto; University of British Columbia; Canadian... and other collaborators

Completed

Reducing Post-discharge Adverse Drug Events Amongst the Elderly: a Multi-centre Electronic Deprescribing Intervention

Adverse Drug Event

Canada
Abbott Medical Devices

Completed

Lead Registry for Optim Leads (OPTIMUM)

Optim Lead Insulation Related Adverse Events

United States, Belgium, Germany
University of Monastir

Completed

Prognostic Accuracy of the HEART Score in Undifferentiated Chest Pain: A Multicenter Validation Study

Coronary Disease | Risk Factor, Cardiovascular | Coronary Syndrome | Major Adverse Cardiovascular Events

Tunisia
University Hospital of Ferrara

Completed

Angio-based Fractional Flow Reserve to Predict Adverse Events After Stent Implantation (HAWKEYE)

Stents | Prognosis

Italy, Spain
University of Thessaly

Completed

Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio as Predictors for Adverse Events in EVAR

Inflammation in EVAR

Greece
University Hospital Goettingen
Universitätsklinikum Hamburg-Eppendorf; University Hospital, Aachen; Transplantationszentrum...

Completed

Predict Adverse Events by Covid-19 Nephritis

Covid-19

Germany
Spanish Network for Research in Infectious Diseases

Completed

Adverse Events in the Tracheal Intubation in the Intensive Care Unit (INTUPROS)

Intubation | Intubation Complication | Intubation; Difficult or Failed

Spain
Ochsner Health System

Completed

Hydration During Thoracic Surgery

Hospital Length of Stay; Adverse Events
University of Oklahoma

Completed

Efficacy of Aprepitant (Emend®) in Children

Nausea | Vomiting | Childhood Cancer

United States
Shiraz University of Medical Sciences

Completed

Long-term Fasting in Patients With a History of PCI

Coronary Artery Disease

Iran, Islamic Republic of

Search clinical trials for: Adverse Events

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations